MWMark F. Weems

Mark F. Weems

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mark F. Weems has a total of 166 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Variations in diagnosis and management of hemodynamically significant patent ductus arteriosus across neonatal intensive care units in the Children’s Hospitals Neonatal Consortium

    by Sharada H. Gowda, Philip T. Levy, Shannon Hamrick, Sarah Keene, Shawn Sen, Ayan Rajgarhia, Rakesh Rao, Molly K. Ball, Mark F. Weems

    Objective: Collate patent ductus arteriosus (PDA) guidelines among Children’s Hospitals Neonatal Consortium (CHNC) centers and identify variations in the diagnosis and management of hemodynamically significant PDA (hsPDA). Study Design: A descriptive survey requesting written PDA guidelines was sent to CHNC representatives from November 2023 to February 2024. Our study methods were performed in accordance with the survey guidelines and regulations of the CHNC. No PHI identifiers or institutional data were utilized for performing this study. Results: Of 44 centers, 38 (86%) responded; 25 (67%) provided written guidelines. Clinical signs of PDA were included in 18 (72%) guidelines, and 21 (84%) specified echocardiographic criteria for hsPDA. Ibuprofen was the most common first-line therapy, followed by acetaminophen and indomethacin. Most centers outlined a stepwise management approach including fluid restriction, diuretics, pharmacotherapy, and transcatheter closure. Surgical ligation was less frequently recommended. Conclusions: A majority of CHNC centers maintain written hsPDA guidelines incorporating clinical and echocardiographic criteria. Management emphasizes a stepwise approach from expectant to active management with pharmacotherapy and increasing adoption of transcatheter closure, highlighting evolving practice patterns in neonatal PDA care.

  • One Size Does Not Fit All: Comparing CDH Team Structure Across Children's Hospitals in the United States of America

    by Sharada Hiranya Gowda, Thomas Nienaber, Abhishek Makkar, Terry Buchmiller, Mark F. Weems, Jill M. Zalieckas, Tim Jancelewicz, Rebecca Stark, Zeenia Billimoria, Joy M. Perkins, et al.

    Congenital diaphragmatic hernia (CDH) is a complex anomaly with high rates of morbidity and mortality. Successful management depends on interprofessional and multidisciplinary collaboration. Multiple previous publications have underscored the effect that center-specific factors can have on CDH outcomes. However, beyond institutional differences, optimal outcomes also rely on a well-composed team with both surgical and critical care expertise. Understanding the center effect requires identifying key drivers, with team structure being a major factor. While surgeons and neonatologists often lead, maternal–fetal medicine (MFM) specialists and other interdisciplinary members play essential roles. Team composition and ownership vary across centers, shaped by geography, program origins, historical practices, and evolving institutional norms. Describe the variation in CDH-specific care models among sample children's hospitals across the USA. This was a qualitative study evaluating care models among 12 children's hospitals in the USA. Data were obtained by surveying each center with an emphasis on multidisciplinary approach, current practice patterns from fetal diagnosis to discharge and long-term follow-up specific to CDH. We describe a representative sample of 12 children's hospitals whose CDH programs range from primary neonatology service to a dedicated CDH unit and multiple variations of team structure starting from prenatal consults to initiation of extracorporeal life support (ECLS). We found that there is significant heterogeneity in this sample cohort in CDH care models with a common underlying theme of a core team of clinicians with expertise and majority of their dedicated service time allotted to this specific congenital anomaly. Our analysis highlights key elements such as multidisciplinary collaboration and seamless care transition that are essential for optimizing outcomes. A tailored, standardized model incorporating best practices across institutions with available local resources may offer the most practical path toward consistent, high-quality care.

  • Delirium in a level IV NICU: Prevalence & modifiable risk factors

    by Kathryn Martin, Mark F. Weems, Divya Rana

    Objective: We aim to determine delirium prevalence in a Level IV NICU, identify demographic risk factors, controllable risk factors, and associated outcomes. Study Design: Select NICU patients with at least one Cornell Assessment for Pediatric Delirium score, studied over 1 year period. Demographics and outcomes were compared in relation to delirium status. Medication exposure was analyzed prior to 40 weeks PMA and at significant CAPD score events. Result: Prevalence of delirium in the eligible study group was 64%. The delirium group had a lower median gestational age and birthweight, but higher median length of stay, and possible increased mortality rate. Exposure to benzodiazepines was strongly associated with the delirium group, though confounding may exist. Dexmedetomidine was not significantly associated with the delirium group. Conclusions: It is possible that delirium is significantly prevalent and under-recognized among NICU patients, particularly those with lower gestational age and birthweight, and may be associated with poor outcomes. Benzodiazepine exposure may be significantly associated with neonatal delirium onset. Further investigation is needed in this area of study.

  • Open Access

    Variations in Diagnosis and Management of Hemodynamically Significant Patent Ductus Arteriosus Across Neonatal Intensive Care Units in the Children’s Hospitals Neonatal Consortium

    by Sharada Gowda, Philip Levy, Shannon Hamrick, Sarah Keene, Shawn Sen, Ayan Rajgarhia, Rakesh Rao, Molly Ball, Mark Weems

    Objective Collate patent ductus arteriosus (PDA) guidelines among across Children’s Hospitals Neonatal Consortium (CHNC) centers and identify variations in the diagnosis and management of hemodynamically significant PDA (hsPDA). Study Design: A descriptive survey requesting written PDA guidelines was sent to CHNC representatives from November 2023-February 2024. Results Of 44 centers, 38 (86%) responded; 25 (67%) provided written guidelines. Clinical signs of PDA were included in 18 (72%) guidelines, and 21 (84%) specified echocardiographic criteria for hsPDA. Ibuprofen was the most common first-line therapy, followed by acetaminophen and indomethacin. Most centers outlined a stepwise management approach including fluid restriction, diuretics, pharmacotherapy, and transcatheter closure. Surgical ligation was less frequently recommended. Conclusions A majority of CHNC centers maintain written hsPDA guidelines incorporating clinical and echocardiographic criteria. Management emphasizes a step-wise approach from expectant to active management with pharmacotherapy and increasing adoption of transcatheter closure, highlighting evolving practice patterns in neonatal PDA care.

  • Preoperative nutritional strategies for neonates with complex congenital heart disease: a national survey

    by Sharada H. Gowda, Philip T. Levy, Mark Weems, Pamela Griffiths, Siddharth Bommekal, Shannon E. G. Hamrick, Paulomi M. Chaudhry, Molly K. Ball, Robert DiGeronimo

  • Safety of enteral nutrition practices in neonates with umbilical arterial catheters in situ: current evidence to guide clinical practice

    by Giulia Lima, Sarah U. Morton, Amy B. Hair, Misty Good, Mark Weems, Caroline E. Crocker, Patricia Denning, Erika Yazawa, Leeann Pavlek, Eugenia Pallotto, et al.

    Umbilical arterial catheters (UAC) in neonates are used for blood pressure monitoring, blood sampling, administration of fluids, nutrition, and medications. As UAC applications evolve, enteral nutrition practices vary in neonates in the presence of a UAC. The theoretical concern for mesenteric ischemia when a UAC is in place led to early nil per os approaches, delaying the initiation of enteral nutrition. More contemporary practices have favored introducing enteral feeding in neonates with UACs. However, there remains a paucity of data to guide clinical practice approaches regarding enteral feeding in neonates with a UAC in place. In this perspective article, we examine the physiological effects of UACs and review existing literature on feeding practices in neonates with a UAC. We offer an approach to managing enteral feeding in neonates with a UAC, addressing the central question: Is routine feeding in neonates with a UAC in place justified in current clinical practice?


  • Open Access

    Nasal intermittent positive pressure ventilation in neonates with grade 3 bronchopulmonary dysplasia

    by Mark F. Weems, Vineet Lamba, Sandeep Chilakala, L. Brooke Murdock, Divya Rana, Rishika Sakaria, Parul Zaveri, Rangasamy Ramanathan, Lindsay Burgess, Kristen Dabov, et al.

    Objective: We describe a novel strategy of nasal intermittent positive pressure ventilation (NIPPV) to support patients with Grade 3 bronchopulmonary dysplasia (BPD). Study design: This is a retrospective study of Grade 3 BPD patients treated with NIPPV and discharged from a single center from January 2020 to May 2024. Patients were grouped into discharged without tracheostomy vs with tracheostomy. Groups were assessed for clinical differences, and the NIPPV strategy is described. Results: There were 28 non-tracheostomy and 17 tracheostomy patients. There were no differences in gestational age, birthweight, or respiratory severity score at key dates. Tracheostomy patients were more likely to have subglottic stenosis (53% vs 3.6%, p = 0.0001) and were older at discharge home [median 447 (411–479) vs 252 (184–309) days, p < 0.0001]. Conclusion: A subset of Grade 3 BPD patients can be supported with NIPPV. The non-tracheostomy group had decreased length of stay compared to the tracheostomy group.


  • Open Access

    Changes in cardiorespiratory status after transcatheter patent ductus arteriosus closure

    by Camryn Coley, Rishika Sakaria, Ranjit Philip, Shyam Sathanandam, Mark F. Weems

    Objective: We aim to assess short-term cardiorespiratory outcomes of neonates after transcatheter patent ductus arteriosus (PDA) closure. We hypothesize pre-procedure respiratory severity score (RSS) ≥ 4 is associated with increased risk of post-transcatheter cardiorespiratory syndrome (PTCS). Study design: This was a retrospective study of infants who underwent transcatheter PDA closure from January 2022 to December 2022. Patients were divided by pre-procedure RSS and analyzed for the development of PTCS or hypertensive cardiorespiratory failure. Result: The study included 46 patients with a mean birthweight of 699 g and procedure weight of 1098 g. PTCS was identified in 5 (11%) patients with no differences based on pre-procedure RSS (8 vs 14%, p = 0.66). Post-procedure hypertension was found in 28 (61%) patients (58 vs 64%, p = 0.77), and occurred with respiratory failure in 12 (26%) patients (33 vs 18%, p = 0.32). Conclusion: Pre-procedure RSS was not associated with post-procedure outcomes. While PTCS occurred infrequently, post-procedure hypertension was common.


  • Open Access

    Management of the patent ductus arteriosus among infants born at 23 to 32 weeks’ gestation between 2011 to 2022: a report from in the Children’s Hospitals Neonatal Consortium

    by Mark F. Weems, Molly K. Ball, Isabella Zaniletti, Sharifa Habib, Shannon Hamrick, Theresa R. Grover, Sarah Keene, Karna Murthy, Michael Padula, Ranjit Philip, et al.

    Objective: This study reports on patent ductus arteriosus (PDA) therapy trends across the Children’s Hospital Neonatal Consortium. Study design: We performed a 12-year (2011–2022) retrospective study of premature infants (< 33 weeks) with a PDA. We utilized descriptive statistics to compare demographic, inpatient, and discharge characteristics in 3-year epochs. Result: From 54,813 infants, 19,843 (36%) had a diagnosis of PDA. Use of pharmacotherapy increased 44% (relative) over time, mostly with increased acetaminophen use. There was a 12.7-fold increase in exposure to multiple PDA medications over the study period. While the rate of definitive closure did not change, use of transcatheter PDA closure increased from 0 to 20.3% and surgical ligation decreased from 25.1% to 3.6%. Conclusion: There has been an increase in the use of multiple pharmacotherapies for PDA, especially among infants born <27 weeks’ gestation. Transcatheter PDA closure has overtaken surgical ligation as the primary method of definitive PDA closure.